The Research and Development team at iOmx Therapeutics is dedicated to discovering and developing first-in-class cancer therapeutics. The team conducts cutting-edge research in biomarker development, bioinformatics, preclinical pharmacology, molecular biology, and protein science to identify and validate novel targets. They collaborate to advance the most promising therapeutic candidates through rigorous preclinical testing, ultimately aiming to deliver innovative treatments to patients.
View all